ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 546 out of 2343

$709K Total Retail Price of All Prescriptions

Rank: 316 out of 2343

140 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,106 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

67 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
ATENOLOL 324 322 1 12
AMLODIPINE BESYLATE 289 286 2 5
ISOSORBIDE MONONITRATE ER 270 270 3 32
DIOVAN 229 216 4 23
ZOLPIDEM TARTRATE 208 208 5 24
METOPROLOL TARTRATE 199 194 6 7
ZETIA 195 183 7 52
CRESTOR 194 179 8 30
OMEPRAZOLE 191 170 9 4
ATORVASTATIN CALCIUM 190 188 10 10
LOVAZA 159 147 11 113
PRAVASTATIN SODIUM 154 142 12 15
NAPROXEN 146 146 13 108
DIOVAN HCT 142 142 14 63
DOXAZOSIN MESYLATE 140 140 15 98
VOLTAREN 137 135 16 175
RANEXA 135 135 17 272
LISINOPRIL 134 128 18 3
FUROSEMIDE 129 129 19 6
LIPITOR 128 128 20 78
NEXIUM 123 123 21 33
MECLIZINE HCL 119 119 22 103
PLAVIX 117 117 23 38
ONGLYZA 115 115 24 211
HYDROCHLOROTHIAZIDE 110 105 25 11
CLOPIDOGREL 109 109 26 26
DEXILANT 104 104 27 184
WARFARIN SODIUM 102 102 28 8
SIMVASTATIN 100 88 29 1
CYMBALTA 100 100 29 74
TAMSULOSIN HCL 100 100 29 29
LEVOTHYROXINE SODIUM 97 89 32 2
SYNTHROID 93 93 33 40
NITROSTAT 83 83 34 164
METFORMIN HCL 79 79 35 9
SINGULAIR 78 69 36 100
GLIMEPIRIDE 77 77 37 45
NIFEDIPINE ER 76 76 38 89
AMLODIPINE BESYLATE-BENAZEPRIL 76 65 38 59
METOPROLOL SUCCINATE 73 73 40 14
SPIRIVA 69 64 41 48
VESICARE 67 67 42 145
AMITIZA 66 62 43 304
PROAIR HFA 65 65 44 86
CILOSTAZOL 64 64 45 204
LOSARTAN POTASSIUM 63 63 46 19
FINASTERIDE 63 63 46 80
PROCTOZONE-HC 63 62 46 208
DICLOFENAC SODIUM 61 51 49 155
TRAMADOL HCL 58 58 50 25
ZENPEP 58 53 50 353
EXFORGE 56 56 52 163
ADVAIR DISKUS 53 50 53 34
BYSTOLIC 52 52 54 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.